Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia.
Saved in:
| Title: | Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. |
|---|---|
| Authors: | Sonneveld P; Department of Hematology, Cancer Center, University Hospital Rotterdam Dijkzigt Room L407, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. sonneveld@haed.azr.nl, Burnett A, Vossebeld P, Ben-Am M, Rosenkranz G, Pfister C, Verhoef G, Dekker A, Ossenkoppele G, Ferrant C, Yin L, Gratwohl A, Kovacsovics T, Vellenga E, Capdeville R, Löwenberg B |
| Source: | The hematology journal : the official journal of the European Haematology Association [Hematol J] 2000; Vol. 1 (6), pp. 411-21. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100965523 Publication Model: Print Cited Medium: Print ISSN: 1466-4860 (Print) Linking ISSN: 14664860 NLM ISO Abbreviation: Hematol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 11920222 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sonneveld+P%22">Sonneveld P</searchLink>; Department of Hematology, Cancer Center, University Hospital Rotterdam Dijkzigt Room L407, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. sonneveld@haed.azr.nl<br /><searchLink fieldCode="AU" term="%22Burnett+A%22">Burnett A</searchLink><br /><searchLink fieldCode="AU" term="%22Vossebeld+P%22">Vossebeld P</searchLink><br /><searchLink fieldCode="AU" term="%22Ben-Am+M%22">Ben-Am M</searchLink><br /><searchLink fieldCode="AU" term="%22Rosenkranz+G%22">Rosenkranz G</searchLink><br /><searchLink fieldCode="AU" term="%22Pfister+C%22">Pfister C</searchLink><br /><searchLink fieldCode="AU" term="%22Verhoef+G%22">Verhoef G</searchLink><br /><searchLink fieldCode="AU" term="%22Dekker+A%22">Dekker A</searchLink><br /><searchLink fieldCode="AU" term="%22Ossenkoppele+G%22">Ossenkoppele G</searchLink><br /><searchLink fieldCode="AU" term="%22Ferrant+C%22">Ferrant C</searchLink><br /><searchLink fieldCode="AU" term="%22Yin+L%22">Yin L</searchLink><br /><searchLink fieldCode="AU" term="%22Gratwohl+A%22">Gratwohl A</searchLink><br /><searchLink fieldCode="AU" term="%22Kovacsovics+T%22">Kovacsovics T</searchLink><br /><searchLink fieldCode="AU" term="%22Vellenga+E%22">Vellenga E</searchLink><br /><searchLink fieldCode="AU" term="%22Capdeville+R%22">Capdeville R</searchLink><br /><searchLink fieldCode="AU" term="%22Löwenberg+B%22">Löwenberg B</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100965523%22">The hematology journal : the official journal of the European Haematology Association</searchLink> [Hematol J] 2000; Vol. 1 (6), pp. 411-21. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase I; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100965523 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1466-4860 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214664860%22">14664860 </searchLink><i>NLM ISO Abbreviation: </i>Hematol J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=11920222 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/sj.thj.6200050 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 411 Titles: – TitleFull: Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sonneveld P – PersonEntity: Name: NameFull: Burnett A – PersonEntity: Name: NameFull: Vossebeld P – PersonEntity: Name: NameFull: Ben-Am M – PersonEntity: Name: NameFull: Rosenkranz G – PersonEntity: Name: NameFull: Pfister C – PersonEntity: Name: NameFull: Verhoef G – PersonEntity: Name: NameFull: Dekker A – PersonEntity: Name: NameFull: Ossenkoppele G – PersonEntity: Name: NameFull: Ferrant C – PersonEntity: Name: NameFull: Yin L – PersonEntity: Name: NameFull: Gratwohl A – PersonEntity: Name: NameFull: Kovacsovics T – PersonEntity: Name: NameFull: Vellenga E – PersonEntity: Name: NameFull: Capdeville R – PersonEntity: Name: NameFull: Löwenberg B IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2000 Type: published Y: 2000 Identifiers: – Type: issn-print Value: 1466-4860 Numbering: – Type: volume Value: 1 – Type: issue Value: 6 Titles: – TitleFull: The hematology journal : the official journal of the European Haematology Association Type: main |
| ResultId | 1 |
